Bausch named 'stalking horse' in Synergy auction

Bausch Health Companies Inc. (TSX:BHC; NYSE:BHC) bid $200 million to acquire selected assets of Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) in a court-supervised bankruptcy auction, including global rights to gastrointestinal drug Trulance plecanatide.

The agreement makes Bausch the "stalking horse" bidder for those assets...